Parisi Gray Wealth Management raised its position in Danaher Co. (NYSE:DHR) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,215 shares of the conglomerate’s stock after purchasing an additional 436 shares during the quarter. Danaher makes up approximately 1.3% of Parisi Gray Wealth Management’s holdings, making the stock its 18th biggest position. Parisi Gray Wealth Management’s holdings in Danaher were worth $2,935,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hudock Inc. grew its stake in Danaher by 526.3% in the fourth quarter. Hudock Inc. now owns 119 shares of the conglomerate’s stock valued at $26,000 after purchasing an additional 100 shares in the last quarter. Financial Avengers Inc. purchased a new position in Danaher in the fourth quarter valued at about $40,000. Atlas Private Wealth Management purchased a new position in Danaher in the third quarter valued at about $41,000. Oakworth Capital Inc. grew its stake in Danaher by 48.9% in the third quarter. Oakworth Capital Inc. now owns 198 shares of the conglomerate’s stock valued at $43,000 after purchasing an additional 65 shares in the last quarter. Finally, University of Texas Texas AM Investment Managment Co. purchased a new position in Danaher in the third quarter valued at about $53,000. Hedge funds and other institutional investors own 78.00% of the company’s stock.
In other Danaher news, SVP Angela S. Lalor sold 6,437 shares of the company’s stock in a transaction that occurred on Friday, February 12th. The stock was sold at an average price of $244.70, for a total value of $1,575,133.90. Following the completion of the transaction, the senior vice president now owns 25,148 shares of the company’s stock, valued at approximately $6,153,715.60. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 11.70% of the company’s stock.
NYSE:DHR traded down $1.13 during mid-day trading on Tuesday, hitting $224.37. 2,422 shares of the company’s stock traded hands, compared to its average volume of 2,625,056. The firm has a 50 day moving average of $237.66 and a two-hundred day moving average of $223.22. Danaher Co. has a 12 month low of $119.60 and a 12 month high of $248.86. The firm has a market capitalization of $159.39 billion, a price-to-earnings ratio of 45.65, a price-to-earnings-growth ratio of 1.92 and a beta of 0.72. The company has a current ratio of 2.08, a quick ratio of 1.68 and a debt-to-equity ratio of 0.63.
Danaher (NYSE:DHR) last announced its earnings results on Thursday, January 28th. The conglomerate reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.24. The firm had revenue of $6.76 billion during the quarter, compared to the consensus estimate of $6.62 billion. Danaher had a return on equity of 12.94% and a net margin of 18.05%. The firm’s revenue for the quarter was up 38.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.28 EPS. As a group, equities research analysts expect that Danaher Co. will post 6.05 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Monday, December 28th were issued a $0.18 dividend. The ex-dividend date was Thursday, December 24th. This represents a $0.72 annualized dividend and a yield of 0.32%. Danaher’s dividend payout ratio (DPR) is 16.29%.
Several analysts have recently issued reports on DHR shares. Credit Suisse Group upped their price target on Danaher from $260.00 to $264.00 and gave the stock an “outperform” rating in a research note on Thursday, January 14th. The Goldman Sachs Group started coverage on Danaher in a research note on Wednesday, December 2nd. They set a “buy” rating and a $250.00 price target for the company. Royal Bank of Canada downgraded Danaher from an “outperform” rating to a “sector perform” rating and decreased their price target for the stock from $273.00 to $234.00 in a research note on Wednesday, November 25th. KeyCorp started coverage on Danaher in a research note on Monday, November 9th. They set an “overweight” rating and a $280.00 price target for the company. Finally, Needham & Company LLC upped their price target on Danaher from $209.00 to $272.00 in a research note on Tuesday, October 27th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $233.00.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: How to interpret the current ratio
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher and related companies with MarketBeat.com’s FREE daily email newsletter.